COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 12.68
(0.96%)
CNY 12.68
(0.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 98.31 Billion CNY | 6.32% |
| 2022 | 92.46 Billion CNY | 19.13% |
| 2021 | 77.62 Billion CNY | 25.5% |
| 2020 | 61.85 Billion CNY | 35.42% |
| 2019 | 45.67 Billion CNY | 2466.92% |
| 2018 | 1.77 Billion CNY | -4.01% |
| 2017 | 1.85 Billion CNY | -4.64% |
| 2016 | 1.94 Billion CNY | 17.05% |
| 2015 | 1.66 Billion CNY | 10.21% |
| 2014 | 1.5 Billion CNY | 27.61% |
| 2013 | 1.18 Billion CNY | 9.56% |
| 2012 | 1.07 Billion CNY | 20.64% |
| 2011 | 893.44 Million CNY | 8.9% |
| 2010 | 820.42 Million CNY | -2.84% |
| 2009 | 844.38 Million CNY | -8.91% |
| 2008 | 926.99 Million CNY | 44.93% |
| 2007 | 639.62 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 104.45 Billion CNY | 6.25% |
| 2024 Q2 | 114.15 Billion CNY | 9.29% |
| 2024 Q3 | 121.49 Billion CNY | 6.43% |
| 2023 Q2 | 103.65 Billion CNY | 3.09% |
| 2023 Q3 | 102.36 Billion CNY | -1.25% |
| 2023 FY | 98.31 Billion CNY | 6.32% |
| 2023 Q4 | 98.31 Billion CNY | -3.95% |
| 2023 Q1 | 100.54 Billion CNY | 8.73% |
| 2022 Q3 | 93.29 Billion CNY | 1.02% |
| 2022 FY | 92.46 Billion CNY | 19.13% |
| 2022 Q4 | 92.46 Billion CNY | -0.89% |
| 2022 Q2 | 92.35 Billion CNY | 2.0% |
| 2022 Q1 | 90.54 Billion CNY | 16.64% |
| 2021 FY | 77.62 Billion CNY | 25.5% |
| 2021 Q3 | 80.42 Billion CNY | 3.88% |
| 2021 Q1 | 73.93 Billion CNY | 19.53% |
| 2021 Q4 | 77.62 Billion CNY | -3.48% |
| 2021 Q2 | 77.42 Billion CNY | 4.72% |
| 2020 Q2 | 57.93 Billion CNY | 11.29% |
| 2020 Q4 | 61.85 Billion CNY | 0.28% |
| 2020 FY | 61.85 Billion CNY | 35.42% |
| 2020 Q1 | 52.05 Billion CNY | 13.97% |
| 2020 Q3 | 61.67 Billion CNY | 6.47% |
| 2019 FY | 45.67 Billion CNY | 2466.92% |
| 2019 Q3 | 47.13 Billion CNY | 12.95% |
| 2019 Q4 | 45.67 Billion CNY | -3.1% |
| 2019 Q2 | 41.73 Billion CNY | -2.07% |
| 2019 Q1 | 42.61 Billion CNY | 2295.0% |
| 2018 Q4 | 1.77 Billion CNY | -5.0% |
| 2018 Q1 | 1.95 Billion CNY | 5.51% |
| 2018 FY | 1.77 Billion CNY | -4.01% |
| 2018 Q3 | 1.87 Billion CNY | -12.15% |
| 2018 Q2 | 2.13 Billion CNY | 9.0% |
| 2017 Q2 | 1.95 Billion CNY | -2.19% |
| 2017 Q3 | 1.94 Billion CNY | -0.91% |
| 2017 Q4 | 1.85 Billion CNY | -4.48% |
| 2017 Q1 | 2 Billion CNY | 3.0% |
| 2017 FY | 1.85 Billion CNY | -4.64% |
| 2016 Q4 | 1.94 Billion CNY | 0.3% |
| 2016 FY | 1.94 Billion CNY | 17.05% |
| 2016 Q2 | 1.95 Billion CNY | 14.26% |
| 2016 Q3 | 1.93 Billion CNY | -0.9% |
| 2016 Q1 | 1.71 Billion CNY | 3.08% |
| 2015 Q2 | 1.42 Billion CNY | -4.54% |
| 2015 FY | 1.66 Billion CNY | 10.21% |
| 2015 Q4 | 1.66 Billion CNY | 11.79% |
| 2015 Q3 | 1.48 Billion CNY | 4.47% |
| 2015 Q1 | 1.48 Billion CNY | -1.15% |
| 2014 Q2 | 1.27 Billion CNY | 3.68% |
| 2014 Q4 | 1.5 Billion CNY | 11.66% |
| 2014 FY | 1.5 Billion CNY | 27.61% |
| 2014 Q1 | 1.22 Billion CNY | 3.89% |
| 2014 Q3 | 1.34 Billion CNY | 6.11% |
| 2013 Q2 | 883.88 Million CNY | 6.34% |
| 2013 Q1 | 831.2 Million CNY | -22.88% |
| 2013 Q4 | 1.18 Billion CNY | 1.97% |
| 2013 FY | 1.18 Billion CNY | 9.56% |
| 2013 Q3 | 1.15 Billion CNY | 31.02% |
| 2012 Q1 | 967.2 Million CNY | 8.26% |
| 2012 Q2 | 1.08 Billion CNY | 11.82% |
| 2012 Q3 | 1.04 Billion CNY | -3.72% |
| 2012 Q4 | 1.07 Billion CNY | 3.5% |
| 2012 FY | 1.07 Billion CNY | 20.64% |
| 2011 Q1 | 855.53 Million CNY | 4.28% |
| 2011 FY | 893.44 Million CNY | 8.9% |
| 2011 Q4 | 893.44 Million CNY | -2.23% |
| 2011 Q3 | 913.85 Million CNY | 0.03% |
| 2011 Q2 | 913.6 Million CNY | 6.79% |
| 2010 FY | 820.42 Million CNY | -2.84% |
| 2010 Q1 | 860.66 Million CNY | 1.93% |
| 2010 Q3 | 842.85 Million CNY | -0.54% |
| 2010 Q4 | 820.42 Million CNY | -2.66% |
| 2010 Q2 | 847.4 Million CNY | -1.54% |
| 2009 Q4 | 844.38 Million CNY | 0.0% |
| 2009 FY | 844.38 Million CNY | -8.91% |
| 2008 FY | 926.99 Million CNY | 44.93% |
| 2007 FY | 639.62 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 268.3 Billion CNY | 63.357% |